EU Policy update (Summer 2014)
New leaders of the European Institutions We left you before the summer break with updates on the composition of the new European Parliament coming out from the elections of May 2014. As from July, i ...

Read more

EFA Training on EMA
EFA training for patient experts on allergy, asthma and COPD on getting involved with the European Medicines Agency (EMA) As we informed you in the last issue of our eZine, EFA planned to host on 18 ...

Read more

EFA training on involvement with the EMA
Rationale: 12 patient experts from EFA member associations will have the opportunity to discover what the European Medicines Agency (EMA) is and especially how patients can be involved in its activiti ...

Read more

New EMA Video: The Black Triangle
EMA has just published new informative materials on "black triangle" which is the sign that identifies medicines that are being monitored particularly closely. A video on the topic is available with t ...

Read more

EMA Workshop: Best expertise vs conflicts of interests
This workshop is intended to elicit the views and concerns from academia, patient organisations, Committee representatives, non-governmental organisations, the pharmaceutical industry and the scientif ...

Read more

EFA at the PCWP of the European Medicines Agency (EMA)
On the 28th of February, EFA attended one of the periodical joint meetings of the PCWP and the Healthcare Professionals’ Working Group (HCP WG) at the EMA in London. EFA, which has been taking part in ...

Read more

EFA at EMA meetings
On 30th November EFA board member Lina Buzermaniene and EFA COPD advisor Michael Wilken took part in the Patients and Consumers Working Party (PCWP) meeting at the European Medicines Agency (EMA), whi ...

Read more

EMA adopts implementation plan for its 'Road map to 2015'
The management board of the European Medicines Agency (EMA) has adopted a new document entitled "Implementing the European Medicines Agency's Road map to 2015: The Agency's contribution to Science, Me ...

Read more

EMA Patients and Consumer Working Party meetings
  On 16 & 17 June in London, EFA board member Lina Buzermaniene attended a joint meeting of the European Medicines Agency‘s (EMA) Patients and Consumers Working Party (PCWP) and Healthcare ...

Read more

New treatment for people with COPD
At the American Thoracic Society meeting this May the results of two major studies demonstrating the effectiveness of a new treatment in the improvement of lung functioning of people with severe COPD, ...

Read more

Recommendations on EMA's communications on medicines
A new independent survey commissioned by the European Medicines Agency (EMA) and carried out by Dr Frederic Bouder has provided several new recommendations on how the EMA – which is responsible for th ...

Read more

EMA stakeholders' forum onmedicine safetylegislation
The first stakeholder meeting on implementing the new EU medicine safety legislation (pharmacovigilance legislation) was held at the headquartersof theEuropean Medicines Agency in April with the parti ...

Read more

EMA launches Public consultation on its Road Map to 2015
n January 2010 the European Medicine Agency (EMA) made available the draft of its road map “The Agency’s Contribution to Science, Medicines and Health” for a public consultation which will last until  ...

Read more

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team